SCHEMBL24256824

SCHEMBL24256824

c1ccc(-c2cc(-c3ccccc3)nc(-c3ccc(-c4ccc(N(c5cccc6ccccc56)c5cccc6ccccc56)cc4)c4oc5ccccc5c34)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC14B O60729 2/20 0.37
CDC14A Q9UNH5 2/20 0.37
MAPT P10636 6/20 0.34
ALDH1A1 P00352 5/20 0.34
KDM4E B2RXH2 4/20 0.34
HPGD P15428 4/20 0.34
ALOX5 P09917 1/20 0.34
KMT2A Q03164 6/20 0.33
POLB P06746 2/20 0.33
MAPK1 P28482 2/20 0.33
CYP17A1 P05093 1/20 0.33
CYP19A1 P11511 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
LMNA P02545 2/20 0.32
TSHR P16473 2/20 0.32
HTT P42858 1/20 0.32
ADK P55263 1/20 0.32
ACACA Q13085 1/20 0.32
ENPP3 O14638 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26571881 0.86 TP53 (0.31) MAPTALDH1A1KDM4EHPGDC5AR1
SCHEMBL24256102 0.84 CDC14B (0.37) CDC14BCDC14AMAPTALDH1A1KDM4E
SCHEMBL25802263 0.84 CDC14B (0.35) CDC14BCDC14AMAPTALDH1A1KDM4E
SCHEMBL24256088 0.84 CDC14B (0.37) CDC14BCDC14AMAPTALDH1A1KDM4E
SCHEMBL24256817 0.83 CDC14B (0.36) CDC14BCDC14AMAPTALDH1A1KDM4E
SCHEMBL26385246 0.82 CYP1A1 (0.43) CDC14BCDC14AMAPTALDH1A1KDM4E
SCHEMBL24066173 0.82 MAPT (0.34) MAPTALDH1A1KDM4EHPGDKMT2A
SCHEMBL26420903 0.81 ALDH1A1 (0.32) MAPTALDH1A1KDM4EHPGDKMT2A
SCHEMBL25057651 0.81 ALDH1A1 (0.42) CDC14BCDC14AMAPTALDH1A1KDM4E
SCHEMBL24255849 0.81 ALDH1A1 (0.42) CDC14BCDC14AMAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-09-14 US disclosed
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-09-14 US disclosed
EP-4201930-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT Materials Co., Ltd. (KR) 2023-06-28 EP disclosed
WO-2022035224-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE 엘티소재주식회사 2022-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 CDC14B 2445/4885CDC14A 2152/4885MAPT 376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.